Calgary, Canada

Tomoyuki Kawamura

This inventor holds 1 USPTO granted patent. Top assignee: University Technologies International, Inc.. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomoyuki Kawamura. Retrieved from https://idiyas.com/inventor/tomoyuki-kawamura-2ksqycdb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Tomoyuki Kawamura in Diabetes Prevention

Introduction

Tomoyuki Kawamura is an accomplished inventor based in Calgary, Canada. He has made significant contributions to the field of diabetes research, particularly in the prevention and treatment of type I diabetes. His innovative approach has the potential to impact the lives of many individuals affected by this condition.

Latest Patents

Kawamura holds 1 patent related to diabetes prevention and treatment. This patent outlines a method for preventing or treating type I diabetes in mammals. The invention involves administering an effective amount of at least one compound of a specific formula. Additionally, it provides pharmaceutical preparations that are useful for the prevention and/or treatment of type I diabetes, which include a pharmaceutically acceptable carrier.

Career Highlights

Tomoyuki Kawamura is associated with University Technologies International, Inc., where he continues to work on innovative solutions in the medical field. His dedication to research and development has positioned him as a notable figure in diabetes treatment advancements.

Collaborations

Kawamura collaborates with Ji-Won Yoon, contributing to the collective efforts in advancing diabetes research and treatment methodologies.

Conclusion

Tomoyuki Kawamura's work in diabetes prevention and treatment showcases his commitment to improving health outcomes through innovation. His contributions are vital in the ongoing battle against type I diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…